Research / ACCS / Fundamental state Inspectable configuration
State dimensions Filing 0001654954-24-005891 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
271.72% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.23% · OPTIONAL · VALID
Operating cash generation 30th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
14.16% · OPTIONAL · VALID
Revenue growth 0th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-19.23% · CORE · VALID
Gross margin 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
75.28% · CORE · VALID
Operating margin 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-0.75% · CORE · VALID
R&D intensity 100th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
9.39% · OPTIONAL · VALID
SBC intensity 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
-0.96% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 70 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/8 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 7/8 normalized Level 3 Jun 30, 2024 7/8 normalized Level 3 Sep 30, 2024 7/8 normalized Level 3 Dec 31, 2024 6/7 normalized Level 3 Mar 31, 2025 7/8 normalized Level 3 Jun 30, 2025 7/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 59.66%
Current 271.72%
Delta 212.06% Capex Intensity Increased
Previous 0.07%
Current 0.23%
Delta 0.15% Cash Generation Increased
Previous 9.17%
Current 14.16%
Delta 4.99% Growth Decreased
Previous 41.95%
Current -19.23%
Delta -61.17% Margin Decreased
Previous 76.24%
Current 75.28%
Delta -0.96% Profitability Decreased
Previous 8.44%
Current -0.75%
Delta -9.18% R And D Intensity Increased
Previous 7.64%
Current 9.39%
Delta 1.75% Sbc Intensity Decreased
Previous 4.09%
Current -0.96%
Delta -5.05% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.